HIGHLIGHTS
- who: Jinyong Kim from the This is a retrospective cohort study of the breast cancer patients with pathogenic gBRCA1/, mutations from October , to December , at Seoul National University Hospital, Seoul, KoreaThe patients with breast have published the article: Mutations of, in the Journal: (JOURNAL) of 20,/07/2019
- what: The authors analyzed the targeted sequencing data of Korean patients with gBRCA1/2 mutations to investigate the alterations in HR-related genes and their clinical implications. Survival benefit was observed in the TP53 mutants of patients with gBRCA2 mutations compared to those with TP53 wild types . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.